 | Up a level |
Trottet, Cécile; Allam, Ahmed; Horvath, Aron N; Finckh, Axel; Hügle, Thomas; Adler, Sabine; Kyburz, Diego; Micheroli, Raphael; Krauthammer, Michael; Ospelt, Caroline (2024). Explainable deep learning for disease activity prediction in chronic inflammatory joint diseases. PLOS digital health, 3(6) Public Library of Science 10.1371/journal.pdig.0000422
Christ, Lisa; Kissling, Seraphina; Finckh, Axel; Fisher, Benjamin A; Adler, Sabine; Maurer, Britta; Möller, Burkhard; Kollert, Florian (2024). Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohort. Arthritis research & therapy, 26(68) BioMed Central 10.1186/s13075-024-03302-z
Vallejo-Yagüe, Enriqueta; Burkard, Theresa; Finckh, Axel; Burden, Andrea Michelle (2024). Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open, 14(2), e074864.. BMJ Publishing Group 10.1136/bmjopen-2023-074864
Mongin, Denis; Pagano, Sabrina; Lamacchia, Celine; Juillard, Catherine; Antinori-Malaspina, Paola; Dan, Diana; Ciurea, Adrian; Möller, Burkhard; Gabay, Cem; Finckh, Axel; Vuilleumier, Nicolas (2024). Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis. Frontiers in cardiovascular medicine, 11(1386192) Frontiers 10.3389/fcvm.2024.1386192
Riek, Myriam; Scherer, Almut; Möller, Burkhard; Ciurea, Adrian; von Mühlenen, Ines; Gabay, Cem; Kyburz, Diego; Brulhart, Laure; von Kempis, Johannes; Mueller, Ruediger B; Hasler, Paul; Strahm, Tanja; von Känel, Sabine; Zufferey, Pascal; Dudler, Jean; Finckh, Axel (2023). Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Scientific Reports, 13(1), p. 17776. Nature Publishing Group 10.1038/s41598-023-44841-w
Burkard, Theresa; Vallejo-Yagüe, Enriqueta; Lauper, Kim; Finckh, Axel; Hügle, Thomas; Burden, Andrea M (2023). Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab. RMD open, 9(4), e003396. BMJ Publishing Group 10.1136/rmdopen-2023-003396
Micheroli, Raphael; Kissling, Seraphina; Bürki, Kristina; Möller, Burkhard; Finckh, Axel; Nissen, Michael J; Exer, Pascale; Bräm, René; Kyburz, Diego; Rubbert-Roth, Andrea; Andor, Michael; Baraliakos, Xenofon; de Hooge, Manouk; Distler, Oliver; Scherer, Almut; Ciurea, Adrian (2023). Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry. Clinical rheumatology, 42(9), pp. 2377-2385. Springer 10.1007/s10067-023-06662-0
Iudici, Michele; Hemmig, Andrea Katharina; Stegert, Mihaela; Courvoisier, Courvoisier; Adler, Sabine; Becker, Mike Oliver; Berger, Christoph T; Dan, Diana; Finckh, Axel; Mahr, Alfred; Neumann, Thomas; Reichenbach, Stephan; Ribi, Camillo; Seitz, Luca; Villiger, Peter; Wildi, Lukas; Daikeler, Thomas (2023). Management of giant-cell arteritis in Switzerland: an online national survey. Swiss medical weekly, 153(40051), p. 40051. SMW supporting association 10.57187/smw.2023.40051
Amstad, Andrea; Papagiannoulis, Eleftherios; Scherer, Almut; Rubbert-Roth, Andrea; Finckh, Axel; Mueller, Ruediger; Dudler, Jean; Möller, Burkhard; Villiger, Peter M; Schulz, Martin M P; Kyburz, Diego (2022). Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. Rheumatology, 62(1), pp. 89-97. Oxford University Press 10.1093/rheumatology/keac285
Seo, Michael; Debray, Thomas Pa; Ruffieux, Yann; Gsteiger, Sandro; Bujkiewicz, Sylwia; Finckh, Axel; Egger, Matthias; Efthimiou, Orestis (2022). Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions. Statistical Methods in Medical Research, 31(7), pp. 1355-1373. SAGE Publications (UK and US) 10.1177/09622802221090759
Vallejo-Yagüe, Enriqueta; Pfund, Julia N; Burkard, Theresa; Clair, Carole; Micheroli, Raphael; Möller, Burkhard; Finckh, Axel; Burden, Andrea M (2022). Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort. PLoS ONE, 17(10), e0275026. Public Library of Science 10.1371/journal.pone.0275026
Raptis, Catherine E; Berger, Christoph T; Ciurea, Adrian; Andrey, Diego O; Polysopoulos, Christos; Lescuyer, Pierre; Maletic, Tanja; Riek, Myriam; Scherer, Almut; von Loga, Isabell; Safford, Judith; Lauper, Kim; Möller, Burkhard; Vuilleumier, Nicolas; Finckh, Axel; Rubbert-Roth, Andrea (2022). Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. Frontiers in immunology, 13(1016927), p. 1016927. Frontiers Research Foundation 10.3389/fimmu.2022.1016927
Vallejo-Yagüe, Enriqueta; Burkard, Theresa; Möller, Burkhard; Finckh, Axel; Burden, Andrea M (2021). Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland. Journal of clinical medicine, 10(14) MDPI 10.3390/jcm10143194
Ciurea, Adrian; Papagiannoulis, Eleftherios; Bürki, Kristina; von Loga, Isabell; Micheroli, Raphael; Möller, Burkhard; Rubbert-Roth, Andrea; Andor, Michael; Bräm, René; Müller, Angela; Dan, Diana; Kyburz, Diego; Distler, Oliver; Scherer, Almut; Finckh, Axel (2021). Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Annals of the rheumatic diseases, 80(2), pp. 238-241. BMJ Publishing Group 10.1136/annrheumdis-2020-218705
Möller, Burkhard; Aletaha, Daniel; Andor, Michael; Atkinson, Andrew; Aubry-Rozier, Bérengère; Brulhart, Laure; Dan, Diana; Finckh, Axel; Grobéty, Véronique; Mandl, Peter; Micheroli, Raphael; Nissen, Michael John; Nydegger, Alexander M; Scherer, Almut; Tamborrini, Giorgio; Ziswiler, Hans-Rudolf; Zufferey, Pascal (2020). Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years. Rheumatology, 59(7), pp. 1556-1565. Oxford University Press 10.1093/rheumatology/kez460
Zufferey, Pascal; Courvoisier, Delphine S; Nissen, Michael J; Möller, Burkhard; Brulhart, Laure; Ziswiler, Hans Ruedi; Tamborrini, Giorgio; Ciurea, Adrian; D'Agostino, Maria-Antonietta; Finckh, Axel (2020). Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life. Joint bone spine, 87(1), pp. 57-62. Elsevier 10.1016/j.jbspin.2019.09.010
Alpizar-Rodriguez, Deshire; Förger, Frauke; Courvoisier, Delphine Sophie; Gabay, Cem; Finckh, Axel (2019). Role of reproductive and menopausal factors in functional and structural progression of rheumatoid arthritis: results from the SCQM cohort. Rheumatology, 58(3), pp. 432-440. Oxford University Press 10.1093/rheumatology/key311
Scholz, Godehard A.; Leichtle, Alexander B.; Scherer, Almut; Arndt, Uta; Fiedler, Martin; Aeberli, Daniel; Finckh, Axel; Gabay, Cem; Kyburz, Diego; Villiger, Peter M.; Möller, Burkhard (2019). The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. British journal of haematology, 186(1), pp. 101-112. Wiley-Blackwell 10.1111/bjh.15895
Didden, EM; Ruffieux, Y; Hummel, N; Efthimiou, O; Reichenbach, S; Gsteiger, Sandro; Finckh, Axel; Fletcher, Christine; Salanti, G; Egger, Matthias; Work Package, IMI GetReal (2018). Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis. Medical decision making, 38(6), pp. 719-729. Sage Publications 10.1177/0272989X18775975
Möller, Burkhard; Everts-Graber, Judith; Florentinus, Stefan; Li, Yihan; Kupper, Hartmut; Finckh, Axel (2018). Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III Trial. Arthritis care & research, 70(6), pp. 861-868. Wiley-Blackwell 10.1002/acr.23427
Hebeisen, Monika; Neuenschwander, Regula; Scherer, Almut; Exer, Pascale; Weber, Ulrich; Tamborrini, Giorgio; Micheroli, Raphael; Wildi, Lukas M; Zufferey, Pascal; Nissen, Michael J; Villiger, Peter; Bernhard, Jürg; Finckh, Axel; van der Horst-Bruinsma, Irene E; Sieper, Joachim; Landewé, Robert; van der Heijde, Désirée; Ciurea, Adrian (2018). Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort. The journal of rheumatology, 45(4), pp. 506-512. The Journal of Rheumatology Publishing Company Limited 10.3899/jrheum.170166
Alpizar-Rodriguez, Deshiré; Mueller, Rüdiger B.; Möller, Burkhard; Dudler, Jean; Ciurea, Adrian; Zufferey, Pascal; Kyburz, Diego; Walker, Ulrich A.; von Mühlenen, Ines; Roux-Lombard, Pascale; Mahler, Michael; Lamacchia, Celine; Courvoisier, Delphine S.; Gabay, Cem; Finckh, Axel (2017). Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis. Rheumatology, 56(9), pp. 1579-1585. Oxford University Press 10.1093/rheumatology/kex239
Alpizar-Rodriguez, D; Brulhart, Laure; Mueller, Ruediger B.; Möller, Burkhard; Dudler, Jean; Ciurea, Adrian; Walker, Ulrich A.; Von Mühlenen, Ines; Kyburz, Diego; Zufferey, Pascal; Mahler, Michael; Bas, Sylvette; Gascon, Danielle; Lamacchia, Céline; Roux-Lombard, Pascale; Lauper, Kim; Nissen, Michael J.; Courvoisier, Delphine S.; Gabay, Cem and Finckh, Axel (2017). The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis. Clinical rheumatology, 36(3), pp. 677-682. Springer 10.1007/s10067-017-3547-3
Ditisheim, Saskia; Fournier, Nicolas; Juillerat, Pascal; Pittet, Valerie; Michetti, Pierre; Gabay, Cem; Finckh, Axel; Swiss IBD Cohort, Study Group (2015). Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study. Inflammatory bowel diseases, 21(11), pp. 2598-2604. Lippincott Williams & Wilkins 10.1097/MIB.0000000000000548
Möller, Burkhard; Pruijm, Menno; Adler, Sabine; Scherer, Almut; Villiger, Peter M.; Finckh, Axel (2015). Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study. Annals of the rheumatic diseases, 74(4), pp. 718-723. BMJ Publishing Group 10.1136/annrheumdis-2013-204078
Zufferey, Pascal; Möller, Burkhard; Brulhart, Laure; Tamborrini, Giorgio; Scherer, Almut; Finckh, Axel; Ziswiler, Hans Rudolf (2014). Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study. Joint bone spine, 81(5), pp. 426-432. Elsevier Masson SAS 10.1016/j.jbspin.2014.04.014
Zufferey, Pascal; Brulhart, Laure; Tamborrini, Giorgio; Finckh, Axel; Scherer, Almut; Möller, Burkhard; Ziswiler, Hans Rudolf (2014). Ultrasound evaluation of synovitis in RA: correlation with clinical disease activity and sensitivity to change in an observational cohort study. Joint bone spine, 81(3), pp. 222-227. Elsevier Masson SAS 10.1016/j.jbspin.2013.08.006
Möller, Burkhard; Scherer, Almut; Förger, Frauke; Villiger, Peter; Finckh, Axel (2013). Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study. Annals of the rheumatic diseases, 73(4), pp. 691-696. BMJ Publishing Group 10.1136/annrheumdis-2012-202709
Finckh, Axel; Möller, Burkhard; Dudler, Jean; Walker, Ulrich A; Kyburz, Diego; Gabay, Cem; physicians of the Swiss Clinical Quality Management for Rheumato, ; physicians of SCQM-RA, (2012). Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Annals of the rheumatic diseases, 71(10), pp. 1680-5. London: BMJ Publishing Group 10.1136/annrheumdis-2011-201016
Walker, Ulrich A; Courvoisier, Delphine S; Dudler, Jean; Aeberli, Daniel; von Kempis, Johannes; Scherer, Almut; Finckh, Axel; on behalf of the, Swiss Clinical Quality Management Programme in Rheumatic Disease (2011). Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology, 50(1), pp. 243-244. Oxford: Oxford University Press 10.1093/rheumatology/keq258
Finckh, Axel; Dudler, Jean; Wermelinger, Felix; Ciurea, Adrian; Kyburz, Diego; Gabay, Cem; Bas, Sylvette; physicians of SCQM, (2010). Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. Joint bone spine, 77(4), pp. 313-8. Paris: Elsevier Masson SAS 10.1016/j.jbspin.2010.02.021
Du Pan, Sophie Martin; Dehler, Silvia; Ciurea, Adrian; Ziswiler, Hans-Rudolf; Gabay, Cem; Finckh, Axel (2009). Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis. Arthritis & rheumatism, 61(5), pp. 560-8. Hoboken, N.J.: Wiley-Blackwell 10.1002/art.24463
